Inhibikase Therapeutics Inc Stock price
Is Inhibikase Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Inhibikase Therapeutics Inc Stock Analysis
Analyst Opinions
13 Analysts have issued a Inhibikase Therapeutics Inc forecast:
Analyst Opinions
13 Analysts have issued a Inhibikase Therapeutics Inc forecast:
Don't miss a Thing! We will send you all news about Inhibikase Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Inhibikase Therapeutics Inc Stock News
Company Profile
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMP™ Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
| Head office | United States |
| CEO | Mr. Iwicki |
| Employees | 35 |
| Founded | 2008 |
| Website | www.inhibikase.com |


